ID   ECHA_HUMAN              Reviewed;         763 AA.
AC   P40939; B2R7L4; B4DYP2; Q16679; Q53T69; Q53TA2; Q96GT7; Q9UQC5;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2002, sequence version 2.
DT   10-MAY-2017, entry version 196.
DE   RecName: Full=Trifunctional enzyme subunit alpha, mitochondrial;
DE   AltName: Full=78 kDa gastrin-binding protein;
DE   AltName: Full=TP-alpha;
DE   Includes:
DE     RecName: Full=Long-chain enoyl-CoA hydratase;
DE              EC=4.2.1.17;
DE   Includes:
DE     RecName: Full=Long chain 3-hydroxyacyl-CoA dehydrogenase;
DE              EC=1.1.1.211;
DE   Flags: Precursor;
GN   Name=HADHA; Synonyms=HADH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8135828; DOI=10.1006/bbrc.1994.1302;
RA   Kamijo T., Aoyama T., Komiyama A., Hashimoto T.;
RT   "Structural analysis of cDNAs for subunits of human mitochondrial
RT   fatty acid beta-oxidation trifunctional protein.";
RL   Biochem. Biophys. Res. Commun. 199:818-825(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7918661; DOI=10.1016/0167-4781(94)90091-4;
RA   Zhang Q.X., Baldwin G.S.;
RT   "Structures of the human cDNA and gene encoding the 78 kDa gastrin-
RT   binding protein and of a related pseudogene.";
RL   Biochim. Biophys. Acta 1219:567-575(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RX   PubMed=10075708; DOI=10.1074/jbc.274.12.8077;
RA   Orii K.E., Orii K.O., Souri M., Orii T., Kondo N., Hashimoto T.,
RA   Aoyama T.;
RT   "Genes for the human mitochondrial trifunctional protein alpha- and
RT   beta-subunits are divergently transcribed from a common promoter
RT   region.";
RL   J. Biol. Chem. 274:8077-8084(1999).
RN   [8]
RP   SUBUNIT.
RX   PubMed=8163672; DOI=10.1172/JCI117158;
RA   Kamijo T., Wanders R.J., Saudubray J.-M., Aoyama T., Komiyama A.,
RA   Hashimoto T.;
RT   "Mitochondrial trifunctional protein deficiency. Catalytic
RT   heterogeneity of the mutant enzyme in two patients.";
RL   J. Clin. Invest. 93:1740-1747(1994).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-295; LYS-303; LYS-406;
RP   LYS-505; LYS-540 AND LYS-644, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-756, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-395, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   VARIANT LCHAD DEFICIENCY GLN-510.
RX   PubMed=7811722; DOI=10.1016/0005-2760(94)90064-7;
RA   Ijlst L., Wanders R.J.A., Ushikubo S., Kamijo T., Hashimoto T.;
RT   "Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase
RT   deficiency: identification of the major disease-causing mutation in
RT   the alpha-subunit of the mitochondrial trifunctional protein.";
RL   Biochim. Biophys. Acta 1215:347-350(1994).
RN   [15]
RP   VARIANT AFLP GLN-510.
RX   PubMed=7846063; DOI=10.1073/pnas.92.3.841;
RA   Sims H.F., Brackett J.C., Powell C.K., Treem W.R., Hale D.E.,
RA   Bennett M.J., Gibson B., Shapiro S., Strauss A.W.;
RT   "The molecular basis of pediatric long chain 3-hydroxyacyl-CoA
RT   dehydrogenase deficiency associated with maternal acute fatty liver of
RT   pregnancy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:841-845(1995).
RN   [16]
RP   CHARACTERIZATION OF VARIANT LCHAD DEFICIENCY GLN-510.
RX   PubMed=8770876; DOI=10.1172/JCI118863;
RA   Ijlst L., Ruiter J.P.N., Hoovers J.M.N., Jakobs M.E., Wanders R.J.A.;
RT   "Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA
RT   dehydrogenase deficiency. Characterization and expression of the
RT   mutant protein, mutation analysis on genomic DNA and chromosomal
RT   localization of the mitochondrial trifunctional protein alpha subunit
RT   gene.";
RL   J. Clin. Invest. 98:1028-1033(1996).
RN   [17]
RP   VARIANTS LCHAD DEFICIENCY PRO-342 AND GLN-510.
RX   PubMed=9266371; DOI=10.1023/A:1005310903004;
RA   Ijlst L., Oostheim W., Ruiter J.P.N., Wanders R.J.A.;
RT   "Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase
RT   deficiency: identification of two new mutations.";
RL   J. Inherit. Metab. Dis. 20:420-422(1997).
RN   [18]
RP   VARIANTS MTPD ASP-282 AND ASN-305.
RX   PubMed=9739053; DOI=10.1172/JCI2091;
RA   Ibdah J.A., Tein I., Dionisi-Vici C., Bennett M.J., Ijlst L.,
RA   Gibson B., Wanders R.J.A., Strauss A.W.;
RT   "Mild trifunctional protein deficiency is associated with progressive
RT   neuropathy and myopathy and suggests a novel genotype-phenotype
RT   correlation.";
RL   J. Clin. Invest. 102:1193-1199(1998).
CC   -!- FUNCTION: Bifunctional subunit.
CC   -!- CATALYTIC ACTIVITY: (3S)-3-hydroxyacyl-CoA = trans-2(or 3)-enoyl-
CC       CoA + H(2)O.
CC   -!- CATALYTIC ACTIVITY: A long-chain (S)-3-hydroxyacyl-CoA + NAD(+) =
CC       a long-chain 3-oxoacyl-CoA + NADH.
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC   -!- SUBUNIT: Octamer of 4 alpha (HADHA) and 4 beta (HADHB) subunits.
CC       {ECO:0000269|PubMed:8163672}.
CC   -!- INTERACTION:
CC       O95166:GABARAP; NbExp=5; IntAct=EBI-356720, EBI-712001;
CC       Q9H0R8:GABARAPL1; NbExp=4; IntAct=EBI-356720, EBI-746969;
CC       P60520:GABARAPL2; NbExp=4; IntAct=EBI-356720, EBI-720116;
CC       Q9GZQ8:MAP1LC3B; NbExp=4; IntAct=EBI-356720, EBI-373144;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P40939-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P40939-2; Sequence=VSP_054358, VSP_054359, VSP_054360,
CC                                  VSP_054361;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Mitochondrial trifunctional protein deficiency (MTPD)
CC       [MIM:609015]: A disease biochemically characterized by loss of all
CC       enzyme activities of the mitochondrial trifunctional protein
CC       complex. Variable clinical manifestations include hypoglycemia,
CC       cardiomyopathy, delayed psychomotor development, sensorimotor
CC       axonopathy, generalized weakness, hepatic dysfunction, respiratory
CC       failure. Sudden infant death may occur. Most patients die from
CC       heart failure. {ECO:0000269|PubMed:9739053}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Long-chain 3-hydroxyl-CoA dehydrogenase deficiency (LCHAD
CC       deficiency) [MIM:609016]: The clinical features are very similar
CC       to TFP deficiency. Biochemically, LCHAD deficiency is
CC       characterized by reduced long-chain 3-hydroxyl-CoA dehydrogenase
CC       activity, while the other enzyme activities of the TFP complex are
CC       normal or only slightly reduced. {ECO:0000269|PubMed:7811722,
CC       ECO:0000269|PubMed:9266371}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Maternal acute fatty liver of pregnancy (AFLP)
CC       [MIM:609016]: Severe maternal illness occurring during pregnancies
CC       with affected fetuses. This disease is associated with LCHAD
CC       deficiency and characterized by sudden unexplained infant death or
CC       hypoglycemia and abnormal liver enzymes (Reye-like syndrome).
CC       {ECO:0000269|PubMed:7846063}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the enoyl-CoA
CC       hydratase/isomerase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the central section; belongs to the 3-hydroxyacyl-
CC       CoA dehydrogenase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D16480; BAA03941.1; -; mRNA.
DR   EMBL; U04627; AAA56664.1; -; mRNA.
DR   EMBL; AK302532; BAG63804.1; -; mRNA.
DR   EMBL; AK313027; BAG35861.1; -; mRNA.
DR   EMBL; AC010896; AAY14643.1; -; Genomic_DNA.
DR   EMBL; AC011742; AAX93141.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00703.1; -; Genomic_DNA.
DR   EMBL; BC009235; AAH09235.1; -; mRNA.
DR   EMBL; AB020811; BAA76735.1; -; Genomic_DNA.
DR   CCDS; CCDS1721.1; -. [P40939-1]
DR   PIR; JC2108; JC2108.
DR   RefSeq; NP_000173.2; NM_000182.4. [P40939-1]
DR   UniGene; Hs.516032; -.
DR   ProteinModelPortal; P40939; -.
DR   SMR; P40939; -.
DR   BioGrid; 109280; 80.
DR   IntAct; P40939; 45.
DR   MINT; MINT-1159893; -.
DR   STRING; 9606.ENSP00000370023; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000000247; -.
DR   iPTMnet; P40939; -.
DR   PhosphoSitePlus; P40939; -.
DR   SwissPalm; P40939; -.
DR   BioMuta; HADHA; -.
DR   DMDM; 20141376; -.
DR   REPRODUCTION-2DPAGE; IPI00031522; -.
DR   UCD-2DPAGE; P40939; -.
DR   EPD; P40939; -.
DR   MaxQB; P40939; -.
DR   PaxDb; P40939; -.
DR   PeptideAtlas; P40939; -.
DR   PRIDE; P40939; -.
DR   DNASU; 3030; -.
DR   Ensembl; ENST00000380649; ENSP00000370023; ENSG00000084754. [P40939-1]
DR   GeneID; 3030; -.
DR   KEGG; hsa:3030; -.
DR   UCSC; uc002rgy.3; human. [P40939-1]
DR   CTD; 3030; -.
DR   DisGeNET; 3030; -.
DR   GeneCards; HADHA; -.
DR   HGNC; HGNC:4801; HADHA.
DR   HPA; HPA015536; -.
DR   HPA; HPA056070; -.
DR   MalaCards; HADHA; -.
DR   MIM; 600890; gene.
DR   MIM; 609015; phenotype.
DR   MIM; 609016; phenotype.
DR   neXtProt; NX_P40939; -.
DR   OpenTargets; ENSG00000084754; -.
DR   Orphanet; 243367; Acute fatty liver of pregnancy.
DR   Orphanet; 5; Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
DR   Orphanet; 746; Mitochondrial trifunctional protein deficiency.
DR   PharmGKB; PA29175; -.
DR   eggNOG; KOG1683; Eukaryota.
DR   eggNOG; COG1024; LUCA.
DR   eggNOG; COG1250; LUCA.
DR   GeneTree; ENSGT00870000136389; -.
DR   HOGENOM; HOG000261346; -.
DR   HOVERGEN; HBG005557; -.
DR   InParanoid; P40939; -.
DR   KO; K07515; -.
DR   OMA; MMMLNEA; -.
DR   OrthoDB; EOG091G02LF; -.
DR   PhylomeDB; P40939; -.
DR   TreeFam; TF352288; -.
DR   BioCyc; MetaCyc:HS01481-MONOMER; -.
DR   Reactome; R-HSA-1482798; Acyl chain remodeling of CL.
DR   Reactome; R-HSA-77285; Beta oxidation of myristoyl-CoA to lauroyl-CoA.
DR   Reactome; R-HSA-77288; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids.
DR   Reactome; R-HSA-77305; Beta oxidation of palmitoyl-CoA to myristoyl-CoA.
DR   Reactome; R-HSA-77310; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA.
DR   Reactome; R-HSA-77346; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA.
DR   Reactome; R-HSA-77348; Beta oxidation of octanoyl-CoA to hexanoyl-CoA.
DR   Reactome; R-HSA-77350; Beta oxidation of hexanoyl-CoA to butanoyl-CoA.
DR   SABIO-RK; P40939; -.
DR   UniPathway; UPA00659; -.
DR   ChiTaRS; HADHA; human.
DR   GenomeRNAi; 3030; -.
DR   PRO; PR:P40939; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000084754; -.
DR   CleanEx; HS_HADH; -.
DR   CleanEx; HS_HADHA; -.
DR   ExpressionAtlas; P40939; baseline and differential.
DR   Genevisible; P40939; HS.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0016507; C:mitochondrial fatty acid beta-oxidation multienzyme complex; IEA:Ensembl.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0003857; F:3-hydroxyacyl-CoA dehydrogenase activity; TAS:ProtInc.
DR   GO; GO:0003985; F:acetyl-CoA C-acetyltransferase activity; TAS:ProtInc.
DR   GO; GO:0004300; F:enoyl-CoA hydratase activity; TAS:ProtInc.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IEA:Ensembl.
DR   GO; GO:0016509; F:long-chain-3-hydroxyacyl-CoA dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016508; F:long-chain-enoyl-CoA hydratase activity; IEA:Ensembl.
DR   GO; GO:0051287; F:NAD binding; IEA:Ensembl.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   Gene3D; 1.10.1040.10; -; 2.
DR   InterPro; IPR006180; 3-OHacyl-CoA_DH_CS.
DR   InterPro; IPR006176; 3-OHacyl-CoA_DH_NAD-bd.
DR   InterPro; IPR006108; 3HC_DH_C.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR013328; 6PGD_dom_2.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom.
DR   InterPro; IPR001753; Crotonase_core_superfam.
DR   InterPro; IPR018376; Enoyl-CoA_hyd/isom_CS.
DR   InterPro; IPR012803; Fa_ox_alpha_mit.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF00725; 3HCDH; 2.
DR   Pfam; PF02737; 3HCDH_N; 1.
DR   Pfam; PF00378; ECH_1; 1.
DR   SUPFAM; SSF48179; SSF48179; 2.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF52096; SSF52096; 1.
DR   TIGRFAMs; TIGR02441; fa_ox_alpha_mit; 1.
DR   PROSITE; PS00067; 3HCDH; 1.
DR   PROSITE; PS00166; ENOYL_COA_HYDRATASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Fatty acid metabolism; Lipid metabolism; Lyase;
KW   Methylation; Mitochondrion; Multifunctional enzyme; NAD;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1     36       Mitochondrion. {ECO:0000255}.
FT   CHAIN        37    763       Trifunctional enzyme subunit alpha,
FT                                mitochondrial.
FT                                /FTId=PRO_0000007403.
FT   SITE        151    151       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   SITE        173    173       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   MOD_RES      46     46       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES      46     46       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES      60     60       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES      60     60       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     129    129       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     166    166       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     166    166       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     213    213       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     214    214       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     214    214       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     230    230       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     249    249       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     249    249       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     289    289       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     295    295       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     303    303       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     303    303       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     316    316       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     326    326       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     326    326       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     334    334       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     334    334       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     350    350       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     350    350       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     353    353       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     395    395       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     399    399       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     406    406       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     406    406       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     411    411       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     411    411       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     415    415       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     419    419       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64428}.
FT   MOD_RES     440    440       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     460    460       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     460    460       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     505    505       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     505    505       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     519    519       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     519    519       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     540    540       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     569    569       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     569    569       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     634    634       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     644    644       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     644    644       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     646    646       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     650    650       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64428}.
FT   MOD_RES     664    664       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     664    664       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     728    728       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     728    728       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     735    735       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     756    756       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     759    759       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   MOD_RES     759    759       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BMS1}.
FT   VAR_SEQ       1     18       MVACRAIGILSRFSAFRI -> MESKGMWQLFELTLPIQS
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054358.
FT   VAR_SEQ      19    105       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054359.
FT   VAR_SEQ     326    347       KFGELVMTKESKALMGLYHGQV -> VNLFPFNVLLSVKGK
FT                                LKIQSSV (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054360.
FT   VAR_SEQ     348    763       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054361.
FT   VARIANT     282    282       V -> D (in MTPD; mild phenotype with
FT                                slowly progressive myopathy and
FT                                sensorimotor polyneuropathy;
FT                                dbSNP:rs137852773).
FT                                {ECO:0000269|PubMed:9739053}.
FT                                /FTId=VAR_021125.
FT   VARIANT     305    305       I -> N (in MTPD; mild phenotype with
FT                                slowly progressive myopathy and
FT                                sensorimotor polyneuropathy;
FT                                dbSNP:rs137852774).
FT                                {ECO:0000269|PubMed:9739053}.
FT                                /FTId=VAR_021126.
FT   VARIANT     342    342       L -> P (in LCHAD deficiency;
FT                                dbSNP:rs137852772).
FT                                {ECO:0000269|PubMed:9266371}.
FT                                /FTId=VAR_021127.
FT   VARIANT     358    358       Q -> K (in dbSNP:rs10200182).
FT                                /FTId=VAR_048908.
FT   VARIANT     510    510       E -> Q (in AFLP and LCHAD deficiency;
FT                                loss of activity; dbSNP:rs137852769).
FT                                {ECO:0000269|PubMed:7811722,
FT                                ECO:0000269|PubMed:7846063,
FT                                ECO:0000269|PubMed:8770876,
FT                                ECO:0000269|PubMed:9266371}.
FT                                /FTId=VAR_002273.
FT   CONFLICT    146    146       L -> V (in Ref. 1; BAA03941).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       V -> L (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       T -> A (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    178    178       A -> I (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    197    198       AL -> VF (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    206    206       S -> N (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    211    211       R -> S (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    576    576       T -> P (in Ref. 2; AAA56664).
FT                                {ECO:0000305}.
FT   CONFLICT    694    694       L -> S (in Ref. 1; BAA03941).
FT                                {ECO:0000305}.
SQ   SEQUENCE   763 AA;  83000 MW;  247FF7B4E48FB484 CRC64;
     MVACRAIGIL SRFSAFRILR SRGYICRNFT GSSALLTRTH INYGVKGDVA VVRINSPNSK
     VNTLSKELHS EFSEVMNEIW ASDQIRSAVL ISSKPGCFIA GADINMLAAC KTLQEVTQLS
     QEAQRIVEKL EKSTKPIVAA INGSCLGGGL EVAISCQYRI ATKDRKTVLG TPEVLLGALP
     GAGGTQRLPK MVGVPAALDM MLTGRSIRAD RAKKMGLVDQ LVEPLGPGLK PPEERTIEYL
     EEVAITFAKG LADKKISPKR DKGLVEKLTA YAMTIPFVRQ QVYKKVEEKV RKQTKGLYPA
     PLKIIDVVKT GIEQGSDAGY LCESQKFGEL VMTKESKALM GLYHGQVLCK KNKFGAPQKD
     VKHLAILGAG LMGAGIAQVS VDKGLKTILK DATLTALDRG QQQVFKGLND KVKKKALTSF
     ERDSIFSNLT GQLDYQGFEK ADMVIEAVFE DLSLKHRVLK EVEAVIPDHC IFASNTSALP
     ISEIAAVSKR PEKVIGMHYF SPVDKMQLLE IITTEKTSKD TSASAVAVGL KQGKVIIVVK
     DGPGFYTTRC LAPMMSEVIR ILQEGVDPKK LDSLTTSFGF PVGAATLVDE VGVDVAKHVA
     EDLGKVFGER FGGGNPELLT QMVSKGFLGR KSGKGFYIYQ EGVKRKDLNS DMDSILASLK
     LPPKSEVSSD EDIQFRLVTR FVNEAVMCLQ EGILATPAEG DIGAVFGLGF PPCLGGPFRF
     VDLYGAQKIV DRLKKYEAAY GKQFTPCQLL ADHANSPNKK FYQ
//
